← back to search

Tatjana Stojaković

Ludwig Boltzmann Institute Applied Diagnostics · AT
Area of research
Epidemiology · Surgery
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Lipoproteins and Cardiovascular Health, Inflammatory Biomarkers in Disease Prognosis, and Diabetes, Cardiovascular Risks, and Lipoproteins.
h-index
57
citations
12,454
works
381
NIH funding
primary concept
email

Recent publications

Inverse association between apolipoprotein C-II and cardiovascular mortality: role of lipoprotein lipase activity modulation
European Heart Journal 2023cited by 20position: middledoi
Hepatocyte‐specific deletion of adipose triglyceride lipase (adipose triglyceride lipase/patatin‐like phospholipase domain containing 2) ameliorates dietary induced steatohepatitis in mice
Hepatology 2021cited by 59position: middledoi
E2F-Family Members Engage the PIDDosome to Limit Hepatocyte Ploidy in Liver Development and Regeneration
Developmental Cell 2020cited by 68position: middledoi
PIDDosome‐induced p53‐dependent ploidy restriction facilitates hepatocarcinogenesis
EMBO Reports 2020cited by 48position: middledoi
Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study
The Lancet Diabetes & Endocrinology 2017cited by 105position: middledoi
Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol
European Heart Journal 2016cited by 676position: middledoi
Prognostic Utility of Galectin-3 for Recurrent Cardiovascular Events During Long-term Follow-up in Patients with Stable Coronary Heart Disease: Results of the KAROLA Study
Clinical Chemistry 2016cited by 24position: middledoi
Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity
Journal of Hepatology 2015cited by 305position: middledoi
Effect of High-Dose Vitamin D <sub>3</sub> on Hospital Length of Stay in Critically Ill Patients With Vitamin D Deficiency
JAMA 2014cited by 508position: middledoi
The Arachidonic Acid Metabolome Serves as a Conserved Regulator of Cholesterol Metabolism
Cell Metabolism 2014cited by 116position: middledoi
Adipocyte cell size, free fatty acids and apolipoproteins are associated with non-alcoholic liver injury progression in severely obese patients
Metabolism 2014cited by 105position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Hubert Scharnagl · University of Graz6 papers (2014–2023)Michael Trauner · Universitätsklinik für Neurologie4 papers (2014–2021)Alain de Bruin · Utrecht University2 papers (2020–2020) · 2 papers (2020–2020)Laura Bongiovanni · Utrecht University2 papers (2020–2020)Bart Westendorp · Utrecht University2 papers (2020–2020)Gerald Timelthaler · University of Vienna2 papers (2020–2021) · 2 papers (2020–2020) · 2 papers (2014–2015) · 2 papers (2020–2020)Valentina C. Sladky · Johns Hopkins Medicine2 papers (2020–2020) · 2 papers (2020–2020)Floris Foijer · Monash University2 papers (2020–2020)Ali Canbay · Charité - Universitätsmedizin Berlin1 papers (2014–2014)Patrick Starlinger · Twitter (United States)1 papers (2020–2020)Jan‐Peter Sowa · University of Louisville1 papers (2014–2014) · 1 papers (2020–2020) · 1 papers (2023–2023) · 1 papers (2014–2014)Heribert Schunkert · German Centre for Cardiovascular Research1 papers (2016–2016)